Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations.
Saved in:
| Title: | Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations. |
|---|---|
| Authors: | Shoukier M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alotaibi AS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alfayez M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cortes J; Georgia Cancer Center at Augusta University, Augusta, Georgia., Samra B; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
| Source: | Cancer [Cancer] 2021 Feb 01; Vol. 127 (3), pp. 381-390. Date of Electronic Publication: 2020 Oct 29. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.33293 |
